These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 25269430)

  • 1. Lipid-based drug carriers for prodrugs to enhance drug delivery.
    Zaro JL
    AAPS J; 2015 Jan; 17(1):83-92. PubMed ID: 25269430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidic prodrug approach for improved oral drug delivery and therapy.
    Markovic M; Ben-Shabat S; Keinan S; Aponick A; Zimmermann EM; Dahan A
    Med Res Rev; 2019 Mar; 39(2):579-607. PubMed ID: 30320896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-Drug Conjugate for Enhancing Drug Delivery.
    Irby D; Du C; Li F
    Mol Pharm; 2017 May; 14(5):1325-1338. PubMed ID: 28080053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-Based Formulations for Oral Drug Delivery: Effects on Drug Absorption and Metabolism.
    Zhu Q; Li X; Xia D; Yu H; Chen D; Fan W; Gan Y
    Curr Drug Metab; 2015; 16(3):200-10. PubMed ID: 26279327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.
    Puri A; Loomis K; Smith B; Lee JH; Yavlovich A; Heldman E; Blumenthal R
    Crit Rev Ther Drug Carrier Syst; 2009; 26(6):523-80. PubMed ID: 20402623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered nanoparticulate drug delivery systems: the next frontier for oral administration?
    Diab R; Jaafar-Maalej C; Fessi H; Maincent P
    AAPS J; 2012 Dec; 14(4):688-702. PubMed ID: 22767270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.
    Rezhdo O; Speciner L; Carrier R
    J Control Release; 2016 Oct; 240():544-560. PubMed ID: 27520734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and applications of lipids as prodrug carriers.
    Lambert DM
    Eur J Pharm Sci; 2000 Oct; 11 Suppl 2():S15-27. PubMed ID: 11033424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art.
    Weber S; Zimmer A; Pardeike J
    Eur J Pharm Biopharm; 2014 Jan; 86(1):7-22. PubMed ID: 24007657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of Lipophilic Prodrugs to Improve Drug Delivery and Efficacy.
    Mandal A; Patel M; Sheng Y; Mitra AK
    Curr Drug Targets; 2016; 17(15):1773-1798. PubMed ID: 26648076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
    Banerjee S; Pillai J
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipid nanoparticles for parenteral delivery of actives.
    Joshi MD; Müller RH
    Eur J Pharm Biopharm; 2009 Feb; 71(2):161-72. PubMed ID: 18824097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.
    Porter CJ; Trevaskis NL; Charman WN
    Nat Rev Drug Discov; 2007 Mar; 6(3):231-48. PubMed ID: 17330072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted lipid based drug conjugates: a novel strategy for drug delivery.
    Vadlapudi AD; Vadlapatla RK; Kwatra D; Earla R; Samanta SK; Pal D; Mitra AK
    Int J Pharm; 2012 Sep; 434(1-2):315-24. PubMed ID: 22692074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the Assessment of Drug Supersaturation and Precipitation In Vitro Using Lipid-Based Delivery Systems.
    Stillhart C; Kuentz M
    J Pharm Sci; 2016 Sep; 105(9):2468-2476. PubMed ID: 26935881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-Based Nanocarriers for Lymphatic Transportation.
    Vishwakarma N; Jain A; Sharma R; Mody N; Vyas S; Vyas SP
    AAPS PharmSciTech; 2019 Jan; 20(2):83. PubMed ID: 30673895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smart design approaches for orally administered lipophilic prodrugs to promote lymphatic transport.
    Elz AS; Trevaskis NL; Porter CJH; Bowen JM; Prestidge CA
    J Control Release; 2022 Jan; 341():676-701. PubMed ID: 34896450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prodrug approaches for enhancing the bioavailability of drugs with low solubility.
    Müller CE
    Chem Biodivers; 2009 Nov; 6(11):2071-83. PubMed ID: 19937841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.